In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors.
Cheam
Ai Lee
AL
World Health Organisation Collaborating Centre for Reference and Research on Influenza, 45 Poplar Road, Parkville, Victoria 3052, Australia.
Barr
Ian G
IG
Hampson
Alan W
AW
Mosse
Jennifer
J
Hurt
Aeron C
AC
D000998:Antiviral Agents / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006146:Guanidines; D009981:Influenza B virus / Q000187:drug effects* / Q000235:genetics; D008826:Microbial Sensitivity Tests; D016296:Mutagenesis; D009439:Neuraminidase / Q000037:antagonists & inhibitors* / Q000235:genetics; D011714:Pyrans; D012794:Sialic Acids / Q000494:pharmacology; D053243:Zanamivir
D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D009439:Neuraminidase; D053243:Zanamivir